Bristol-Myers Squibb Co.
BMY
NYSE
IPO1952
about BMY
Bristol-Myers Squibb Co. is a leading pharmaceutical company focused on developing innovative medicines for diseases such as cancer, immunology, and cardiovascular disorders, providing life-saving treatments to patients worldwide.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $47.00 | $47.35 | $46.78 | $95.10B | 2.76M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$0.64 | n/a | 7.85 | 14.45% | 10.70% | 5.25% |